Chau Minh Duong

Ms. Chau Minh Duong

Clark University
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2021 in Cells
Verified
Journal Article
Open access
PDF file
HNHuyen Thu Nguyen
Huyen Thu Nguyen
Chau Minh DuongChau Minh Duong
Chau Minh Duong
XNXuan-Hung Nguyen
Xuan-Hung Nguyen
UTUYEN THAN
UYEN THAN
Osteoarthritis (OA) is a common degenerative disease that can lead to persistent pain and motion restriction. In the last decade, stem cells, particularly mesenchymal stem cells (MSCs), have been explored as a potential alternative OA therapy due to their regenerative capacity. Furthermore, it has been shown that trophic factors enveloped in extracellular vesicles (EVs), including exosomes, are a crucial aspect of MSC-based treatment for OA. Evidently, EVs derived from different MSC sources might rescue the OA phenotype by targeting many biological processes associated with cartilage extracellular matrix (ECM) degradation and exerting protective effects on different joint cell types. Despite this advancement, different studies employing EV treatment for OA have revealed reverse outcomes depending on the EV cargo, cell source, and pathological condition. Hence, in this review, we aim to summarize and discuss the possible effects of MSC-derived EVs based on recent findings at different stages of OA development, including effects on cartilage ECM, chondrocyte biology, osteocytes and bone homeostasis, inflammation, and pain management. Additionally, we discuss further strategies and technical advances for manipulating EVs to specifically target OA to bring the therapy closer to clinical use.

22 December 2022 in Synlett
Verified
Journal Article
Closed access
PDF file
CJCharles Jakobsche
Charles Jakobsche
MXMuyun Xu
Muyun Xu
NMNicholas S. MacArthur
Nicholas S. MacArthur
Chau Minh DuongChau Minh Duong
Chau Minh Duong
SISaadman Islam
Saadman Islam
JMJoseph P. McElwee
Joseph P. McElwee
Herein, we detail several specific challenges that hinder the effective synthesis of glutamyl hydrazide containing peptides, and we describe a synthetic strategy to work around these challenges. Glutamyl hydrazide is an unnatural amino acid residue that bears an acyl hydrazide functional group on its side chain. This family of compounds has the potential to provide potent and selective inhibitor molecules for several families of enzymes. During peptide synthesis, however, these side chains—even in protected form—can derail the synthesis by initiating undesired side reactions. Avoiding these side reactions is critical for enabling effective access to this family of compounds.